In human Langerhans cells (LCs), CAV-1 is co-localized with C-type lectin receptor langerin, which is capable of HIV capture and transportation of HIV into Birbeck granules (BGs), thus inhibiting HIV infection through the lysosomal degradation pathway [91]. This evidence concerns the gene CAV1 and HIV infectious disease.